Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.73 +0.01 (+0.09%)
At close: Aug 20, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMAA) Assets Average (2025)

Drugs Made In America Acquisition's (DMAA) quarterly Assets Average came in at $238.8 million in Q4 2025, up 1.0% on a QoQ basis from $236.4 million in Q3 2025.

Drugs Made In America Acquisition (DMAA) Assets Average (2025) Analysis & Trends

Drugs Made In America Acquisition (DMAA) has 1 years of Assets Average data on file, last reported at $238.8 million in Q4 2025.

  • Quarterly Assets Average changed N/A year-over-year to $238.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $238.8 million (changed N/A YoY) and the FY2025 annual result came in at $120.2 million, changed N/A from the prior year.
  • Assets Average grew to $238.8 million in Q4 2025, from $236.4 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $238.8 million in Q4 2025 to a low of $116.7 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Launch Two Acquisition 557.86 Mn 557.86 Mn - 244.76 Mn
2 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 509.53 Mn
3 Cantor Equity Partners IV 467.55 Mn 467.55 Mn - 460.97 Mn
4 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 203.86 Mn
5 Aldel Financial 397.49 Mn 397.49 Mn - 246.68 Mn
6 Gores Holdings X 381.05 Mn 380.85 Mn - 373.16 Mn
7 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 371.49 Mn
8 Blue Water Acquisition Corp. III 342.12 Mn 342.08 Mn - 262.54 Mn
9 Berto Acquisition 313.96 Mn 313.81 Mn - 313.08 Mn
10 Drugs Made In America Acquisition 215.52 Mn 215.52 Mn - 193.41 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 238.78 Mn
Sep 30, 2025 236.42 Mn
Jun 30, 2025 234.01 Mn
Mar 31, 2025 116.68 Mn